Aller au contenu principal
Profil bibliographique

Mimouna Seddik

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

17Publications signalées
418Citations signalées
0Affiliations récentes

Les domaines associés

Inflammatory Bowel DiseaseGastrointestinal motility and disordersMicroscopic ColitisTuberculosis Research and EpidemiologyAntifungal resistance and susceptibility

Les publications récentes

2011 article OpenAlex

Un cas d’infection à Clostridium difficile récidivante

Henriette Ya Kissi, Mimouna Seddik, D. Belloula, Philippe Coutarel et autres

L’infection à Clostridium difficile (CD) est une affection nosocomiale commune. Malgré le succès du traitement initial, 15 à 25 % de patients vont récidiver. Le traitement de cette forme d’infection à CD peut être particulièrement problématique. Nous rapportons le cas d’une femme …

fr (code pays fourni par la source)

0 citations Journal Africain d Hépato-Gastroentérologie
2008 article OpenAlex

Interaction of ribavirin with azathioprine metabolism potentially induces myelosuppression

Laurent Peyrin‐Biroulet, J.‐F. CADRANEL, J.‐B. Nousbaum, Abderrahim Oussalah et autres

BACKGROUND: The interaction of ribavirin, an inosine monophosphate dehydrogenase inhibitor, with azathioprine metabolism, potentially leading to myelotoxicity, remains unexplored. AIM: To underline the interaction of ribavirin, an inosine monophosphate dehydrogenase inhibitor, with azathioprine metabolism, potentially leading to myelotoxicity. METHODS: The medical records …

fr, in (code pays fourni par la source)

37 citations Alimentary Pharmacology & Therapeutics
Accès ouvert 2006 article OpenAlex

Successful induction of tolerance to infliximab in patients with Crohn's disease and prior severe infusion reactions

Clotilde Duburque, J. Lelong, Răzvan Iacob, Mimouna Seddik et autres

AIM: To appraise the tolerance and efficacy of an induction of tolerance protocol to infliximab permitting the re-administration of the drug to patients with Crohn's disease having had infusion reactions requiring suspension of treatment. METHODS: Fourteen patients were included in the induction …

fr, ro (code pays fourni par la source)

35 citations Alimentary Pharmacology & Therapeutics
2005 article OpenAlex

Pneumocystis jiroveci (carinii) Pneumonia After Initiation of Infliximab and Azathioprine Therapy in a Patient with Crohnʼs Disease

Mimouna Seddik, Hugues Melliez, D. Séguy, N. Viget et autres

To the Editor: Anti-tumor necrosis factor α therapy is an effective treatment for Crohn's disease. There is an increased risk of infection, including atypical infection associated with infliximab-treated patients. We report a case of a young man who developed Pneumocystis jiroveci pneumonia …

fr (code pays fourni par la source)

24 citations Inflammatory Bowel Diseases
2004 article OpenAlex

Pneumocystis Jiroveci (Carinii) Pneumonia Following Initiation of Infliximab and Azathioprine Therapy in a Patient With Crohnʼs Disease

Mimouna Seddik, Hugues Meliez, D. Séguy, N. Viget et autres

Anti-TNFalpha therapy is an effective treatment of Crohn's disease. There is an increased risk of infection, including atypical infection associated in infliximab treated patients. We report a case of a young man who developed Pneumocystisjiroveci pneumonia shortly after starting therapy with infliximab. …

fr (code pays fourni par la source)

57 citations Inflammatory Bowel Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.